Read the recently published Greater Copenhagen Life Science YEARBOOK 2017 and the editorial “It never get´s easier..” by Medicon Valley Alliance chairman, Søren Bregenholt here. You will also find informative interviews with among others Martin Bonde, Dansk Biotek, CEO, Ida-Sofie Jensen,
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
Mads Krogsgaard Thomsen, Executive vice president and chief science officer of Medicon Valley Alliance board member, Novo Nordisk, has been appointed new chairman of the board of another Medicon Valley Alliance board member, University of Copenhagen. Mads Krogsgaard Thomsen will from
The Medicon Valley Alliance Oncology Network initiated by prof. Carl Borrebaeck (photo) from Lund and prof. Nils Brünner from Copenhagen has already become a central meeting point for Danish and Swedish academia and industry involved in oncology research. Read full article
The MVA board of directors has decided that MVA should actively contribute to the efforts being made to attract the European Medicines Agency to Copenhagen/Medicon Valley. The recently published MVA-analysis ”State of Medicon Valley 2016” provides several convincing arguments documenting
As a regional Danish-Swedish life science cluster organization, Medicon Valley Alliance, is pleased to introduce you to the recently published special Medicon Valley-edition of Affärstidningen Näringsliv titled “Time to Unite – A Greater Medicon Valley” Enjoy the reading and get
Financially and politically, Denmark supported Sweden´s candidacy for The European Spallation Source (ESS) currently under construction in Lund. Consequently, Lord Mayor of Copenhagen, Frank Jensen, now calls for Sweden´s support of Copenhagen´s EMA-candidacy in the “western part” of Greater Copenhagen/Medicon
In an attempt to reach out to the international financial analysts and investment funds in Europe and the United States as well, the bi-weekly newsletter, Nordic Biotech & Pharma, read by the decision makers in the regional Life Science industry, has
The Danish Government has officially announced that Copenhagen is a candidate for The European Medicines Agency (EMA), which is expected to relocate from London following the British decision last summer to leave the European Union. Several other EU-countries, including Sweden,
Eventually, Oxford’s history of “excellence” proved more important than Brexit. Consequently, Novo Nordisk is to invest £115m over 10 years in a new science research centre in Oxford. The research centre, which will work on new ways of treating type 2 diabetes,